| Issue Date |
Title |
Author(s) |
| Apr-2021 |
Aberrant monocyte subsets in patients with Beh & ccedil;et & rsquo;s disease |
Li, Chaoran;Liu, Jinjing;Yu, Xin;Li, Lu;Wang, Zhimian;Shi, Jing;Zeng, Xiaofeng;Zhang, Fengchun;Chen, Hua;Zheng, Wenjie |
| 2017 |
Anti-SmD1 antibodies are associated with renal disorder, seizures, and pulmonary arterial hypertension in Chinese patients with active SLE |
Hu, Chaojun;Li, Mengtao;Liu, Jian;Qian, Junyan;Xu, Dong;Zhang, Shulan;Li, Ping;Zhao, Jiulang;Tian, Xinping;Zeng, Xiaofeng |
| 16-Sep-2020 |
Can low-dose methotrexate reduce effusion-synovitis and symptoms in patients with mid- to late-stage knee osteoarthritis? Study protocol for a randomised, double-blind, and placebo-controlled trial |
Zhu, Zhaohua;Yu, Qinghong;Leng, Xiaomei;Han, Weiyu;Li, Zhanguo;Huang, Cibo;Gu, Jieruo;Zhao, Yi;Wang, Kang;Li, Tianwang;Mei, Yifang;Xu, Jianhua;Zhang, Zhiyi;Hunter, David;Cicuttini, Flavia;Zeng, Xiaofeng;Ding, Changhai |
| Jun-2020 |
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial |
Su, Jinmei;Li, Mengtao;He, Lan;Zhao, Dongbao;Wan, Weiguo;Liu, Yi;Xu, Jianhua;Xu, Jian;Liu, Huaxiang;Jiang, Lindi;Wu, Huaxiang;Zuo, Xiaoxia;Huang, Cibo;Liu, Xiumei;Li, Fen;Zhang, Zhiyi;Liu, Xiangyuan;Dong, Lingli;Li, Tianwang;Chen, Haiying;Li, Jingyang;He, Dongyi;Lu, Xin;Huang, Anbin;Tao, Yi;Wang, Yanyan;Zhang, Zhuoli;Wei, Wei;Li, Xiaofeng;Zeng, Xiaofeng |
| Sep-2020 |
Development and formulation of the classification criteria for osteoarthritis |
Huang, Cibo;Zhang, Zhiyi;Chen, Yaolong;Zhang, Yue;Xing, Dan;Zhao, Like;Lin, Jianhao;Mei, Yifang;Lin, Hsiao-Yi;Zheng, Yi;Tsai, Wei-Chung;Liu, Shengyun;Jiang, Quan;Liu, Yi;Chen, Jinwei;Ye, Zhizhong;Chen, Min;Chen, Yingjuan;Chu, Cong-Qiu;Gao, Ming;He, Lan;Lin, Jin;Wu, Lijun;Xu, Jianhua;Yang, Pinting;Zhang, Xuewu;Jiang, Qing;Lei, Guanghua;Li, Mengtao;Yang, Wanling;Gu, Xin;Zhou, Yixin;He, Dongyi;Liu, Wei;Zhang, Weiya;Ding, Changhai;Zeng, Xiaofeng |
| 17-Jul-2020 |
Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis |
Li, Mengtao;Jing, Zhi-Cheng;Li, Yang;Huo, Yong;Yu, Zaixin;Zhang, Gangcheng;Zhu, Ping;Liu, Jinming;Ji, Qiushang;Wu, Bingxiang;Zhong, Jinhua;Wang, Pingping;Zhu, Wenjing;Zeng, Xiaofeng |
| 2019 |
Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial |
Zhang, Panpan;Gong, Yiyi;Liu, Zheng;Liu, Yanying;Lin, Wei;Li, Jieqiong;Wang, Mu;Liu, Xiaowei;Fei, Yunyun;Chen, Hua;Peng, Linyi;Li, Jing;Zhou, Jiaxin;Shi, Qun;Zhang, Xuan;Shen, Min;Zeng, Xiaofeng;Zhang, Fengchun;Li, Yongzhe;Zhao, Yan;Zhang, Wen |
| 2013 |
Elevated Levels of CD4(+)CD25(+)FoxP3(+) T Cells in Systemic Sclerosis Patients Contribute to the Secretion of IL-17 and Immunosuppression Dysfunction |
Liu, Xinjuan;Gao, Na;Li, Mengtao;Xu, Dong;Hou, Yong;Wang, Qian;Zhang, Guohua;Sun, Qiuning;Zhang, Henghui;Zeng, Xiaofeng |
| 2019 |
Evaluation of a commercial immunoassay for autoantibodies in Chinese Han systemic sclerosis population |
Liu, Chenxi;Hou, Yong;Yang, Yajun;Xu, Dong;Li, Liubing;Li, Jing;Wen, Xiaoting;Zeng, Xiaofeng;Zhang, Fengchun;Li, Yongzhe |
| Oct-2020 |
Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition) |
Zhang, Zhiyi;Huang, Cibo;Jiang, Quan;Zheng, Yi;Liu, Yi;Liu, Shengyun;Chen, Yingjuan;Mei, Yifang;Ding, Changhai;Chen, Min;Gu, Xin;Xing, Dan;Gao, Min;He, Lan;Ye, Zhizhong;Wu, Lijun;Xu, Jianhua;Yang, Pinting;Zhang, Xuewu;Zhang, Yue;Chen, Jinwei;Lin, Jin;Zhao, Like;Li, Mengtao;Yang, Wanling;Zhou, Yixin;Jiang, Qing;Chu, Cong-Qiu;Chen, Yaolong;Zhang, Weiya;Tsai, Wei-Chung;Lei, Guanghua;He, Dongyi;Liu, Wei;Fang, Yongfei;Wu, Darong;Lin, Jianhao;Wei, Cheng-Chung;Lin, Hsiao-Yi;Zeng, Xiaofeng |
| 2012 |
Increase of CD4(+)CD25(+)FoxP(3)(+) T Cell in Patients with Systemic Sclerosis Could Secret IL-17 with Dysfunction of Immunosuppression |
Liu, Xinjuan;Gao, Na;Li, Mengtao;Xu, Dong;Hou, Yong;Wang, Qian;Zhang, Guohua;Sun, Qiuning;Zhang, Henghui;Zeng, Xiaofeng |
| 2019 |
Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study |
Qian, Junyan;Li, Mengtao;Zhang, Xiao;Wang, Qian;Zhao, Jiuliang;Tian, Zhuang;Wei, Wei;Zuo, Xiaoxia;Zhang, Miaojia;Zhu, Ping;Ye, Shuang;Zhang, Wei;Zheng, Yi;Qi, Wufang;Li, Yang;Zhang, Zhuoli;Ding, Feng;Gu, Jieruo;Liu, Yi;Wang, Yanhong;Zeng, Xiaofeng |
| 2019 |
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO SEVERE PA |
Zeng, Xiaofeng;Wang, Yongfu;Jiang, Zhenyu;Zhang, Zhuoli;He, Lan;Zhang, Xiao;Lu, Xin;Liu, Xiumei;Xu, Jian;Huang, Cibo;Liu, Rui;Zuo, Xiaoxia;Zhao, Baozeng;Qiu, Wenting;Chai, Katherine;Guo, Xinjun;Zhang, Xin;Liu, Eugene;Luk, Alvin;Jiang, Weidong;Liu, Scott;Hu, Pei;Chen, Xia |
| 2014 |
Novel Risk Loci for Rheumatoid Arthritis in Han Chinese and Congruence With Risk Variants in Europeans |
Jiang, Lei;Yin, Jian;Ye, Lingying;Yang, Jian;Hemani, Gibran;Liu, Ai-Jun;Zou, Hejian;He, Dongyi;Sun, Lingyun;Zeng, Xiaofeng;Li, Zhanguo;Zheng, Yi;Lin, Yiping;Liu, Yi;Fang, Yongfei;Xu, Jianhua;Li, Yinong;Dai, Shengming;Guan, Jianlong;Jiang, Lindi;Wei, Qianghua;Wang, Yi;Li, Yang;Huang, Cibo;Zuo, Xiaoxia;Liu, Yu;Wu, Xin;Zhang, Libin;Zhou, Ling;Zhang, Qing;Li, Ting;Chen, Ling;Xu, Zhen;Yang, Xiaoping;Qian, Feng;Xie, Weilin;Liu, Wei;Guo, Qian;Huang, Shaolan;Zhao, Jing;Li, Mengmeng;Jin, Yanhua;Gao, Jie;Lv, Ying;Wan |
| 2019 |
Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors |
Zhang, Na;Li, Mengtao;Qian, Junyan;Wang, Qian;Zhao, Jiuliang;Yang, Zhenwen;Tian, Zhuang;Zhang, Xiao;Zuo, Xiaoxia;Zhang, Miaojia;Zhu, Ping;Ye, Shuang;Zhang, Wei;Zheng, Yi;Qi, Wufang;Li, Yang;Zhang, Zhuoli;Ding, Feng;Gu, Jieruo;Liu, Yi;Wei, Wei;Zeng, Xiaofeng |
